Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Rinaldi

Showing results (111-120 of 231) with videos related to

Pageof 24
Sort By:
Biomedicines|February 24, 2024
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel TreatmentsAndrea Mormone, Giovanni Tortorella, Francesca Esposito, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 13, 2020
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antiviralsRiccardo Nevola, Luca Rinaldi, Letizia Zeni, et al.
Frontiers in Medicine|July 19, 2021
The Diabetic Cardiomyopathy: The Contributing Pathophysiological MechanismsTeresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, et al.
Le Infezioni in Medicina|December 25, 2016
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot studyGiuseppe Ruggiero, Aldo Marrone, Ilaria Rainone, et al.
Antioxidants (Basel, Switzerland)|February 13, 2021
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative ReviewLuca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Biomedicines|October 23, 2021
Cardiovascular Benefits from Gliflozins: Effects on Endothelial FunctionTeresa Salvatore, Alfredo Caturano, Raffaele Galiero, et al.
Expert Review of Gastroenterology & Hepatology|January 15, 2021
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antiviralsRiccardo Nevola, Luca Rinaldi, Letizia Zeni, et al.
Atherosclerosis|October 16, 2013
Chronic HCV infection is a risk factor of ischemic strokeLuigi E Adinolfi, Luciano Restivo, Barbara Guerrera, et al.
Journal of Clinical Medicine|September 28, 2024
Unveiling the Burden of Hepatitis A in Salerno, Italy: A Comprehensive 9-Year Retrospective Study (2015-2023) on the Seroprevalence of HAV Antibodies and Age/Sex DistributionEnrica Serretiello, Domenico Iervolino, Giuseppe Di Siervi, et al.
Reviews in Cardiovascular Medicine|March 29, 2022
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney DiseaseRiccardo Nevola, Maria Alfano, Pia Clara Pafundi, et al.
Pageof 24

Showing results (111-120 of 231) with videos related to

Sort By:
Pageof 24
Biomedicines|February 24, 2024
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel TreatmentsAndrea Mormone, Giovanni Tortorella, Francesca Esposito, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 13, 2020
Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antiviralsRiccardo Nevola, Luca Rinaldi, Letizia Zeni, et al.
Frontiers in Medicine|July 19, 2021
The Diabetic Cardiomyopathy: The Contributing Pathophysiological MechanismsTeresa Salvatore, Pia Clara Pafundi, Raffaele Galiero, et al.
Le Infezioni in Medicina|December 25, 2016
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot studyGiuseppe Ruggiero, Aldo Marrone, Ilaria Rainone, et al.
Antioxidants (Basel, Switzerland)|February 13, 2021
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative ReviewLuca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Biomedicines|October 23, 2021
Cardiovascular Benefits from Gliflozins: Effects on Endothelial FunctionTeresa Salvatore, Alfredo Caturano, Raffaele Galiero, et al.
Expert Review of Gastroenterology & Hepatology|January 15, 2021
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antiviralsRiccardo Nevola, Luca Rinaldi, Letizia Zeni, et al.
Atherosclerosis|October 16, 2013
Chronic HCV infection is a risk factor of ischemic strokeLuigi E Adinolfi, Luciano Restivo, Barbara Guerrera, et al.
Journal of Clinical Medicine|September 28, 2024
Unveiling the Burden of Hepatitis A in Salerno, Italy: A Comprehensive 9-Year Retrospective Study (2015-2023) on the Seroprevalence of HAV Antibodies and Age/Sex DistributionEnrica Serretiello, Domenico Iervolino, Giuseppe Di Siervi, et al.
Reviews in Cardiovascular Medicine|March 29, 2022
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney DiseaseRiccardo Nevola, Maria Alfano, Pia Clara Pafundi, et al.
Pageof 24